Carillon Tower Advisers’s Cambrex Corporation CBM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-85,930
Closed -$4.02M 519
2019
Q2
$4.02M Buy
85,930
+1,750
+2% +$73.4K 0.03% 406
2019
Q1
$3.27M Sell
84,180
-2,050
-2% -$84K 0.02% 420
2018
Q4
$3.26M Sell
86,230
-700
-0.8% -$35.4K 0.03% 395
2018
Q3
$5.95M Buy
86,930
+1,695
+2% +$105K 0.04% 368
2018
Q2
$4.46M Sell
85,235
-1,240
-1% -$61.8K 0.04% 393
2018
Q1
$4.52M Buy
+86,475
New +$4.62M 0.04% 379

Other funds holding CBM

Carillon Tower Advisers's CBM Position: Q3 2019 in Review

Carillon Tower Advisers sold out of Cambrex Corporation (CBM) in Q3 2019, closing a stake of 85,930 shares — an estimated $4.02M sold.

Carillon Tower Advisers first reported a position in CBM in Q1 2018 and held it in 6 quarters. The position peaked at $5.95M in Q3 2018. 201 funds tracked by Wall St. Rank hold CBM as of Q3 2019.

  • Carillon Tower Advisers reported no remaining Cambrex Corporation position as of Q3 2019 after selling out during the quarter.
  • Carillon Tower Advisers sold 85,930 Cambrex Corporation shares in Q3 2019, an estimated $4.02M.
  • Carillon Tower Advisers first reported a position in Cambrex Corporation in Q1 2018 and held it in 6 quarters.
  • Carillon Tower Advisers's Cambrex Corporation position peaked at $5.95M in Q3 2018.
  • 201 funds tracked by Wall St. Rank held Cambrex Corporation as of Q3 2019.

Based on Carillon Tower Advisers's 13F filing for Q3 2019, filed 5 Nov 2019.